PATIENT CHARACTERISTICS AND TREATMENT ADHERENCE AMONG PATIENTS TREATED WITH DELAYED-RELEASE DIMETHYL FUMARATE FOR RELAPSING REMITTING MULTIPLE SCLEROSIS IN ISRAEL

被引：0
|
作者：
Desai, U. [1 ]
Huang, M. [2 ]
Kirson, N. Y. [1 ]
King, S. [1 ]
Hellstern, M. [1 ]
Schonfeld, S. [1 ]
Birnbaum, H. G. [1 ]
Lee, A. [2 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Biogen, Cambridge, MA USA
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 05期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND45
引用
收藏
页码：A195 / A195
页数：1
相关论文
共 50 条
  • [1] Absolute Lymphocyte Count in Patients with Relapsing-Remitting Multiple Sclerosis Treated with Delayed-release Dimethyl Fumarate: Considerations for Patient Management
    Fox, Robert
    Chan, Andrew
    Gold, Ralf
    Phillips, J. Theodore
    Yang, Lili
    Liu, Shifang
    Prada, Claudia
    Ray, Soma
    Mehta, Devangi
    Taylor, Catherine
    Fay, Monica
    NEUROLOGY, 2017, 88
  • [2] An interim analysis of quality of life in patients with relapsing-remitting multiple sclerosis treated with delayed-release dimethyl fumarate
    Sarda, S. P.
    Kita, M.
    Fox, R. J.
    Gold, R.
    Giovannoni, G.
    Phillips, T.
    Okwuokenye, M.
    Kong, J.
    Zhang, R.
    Kurukulasuriya, N. C.
    Kappos, L.
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 413 - 414
  • [3] Delayed-Release Dimethyl Fumarate Safety and Efficacy in Pediatric Patients With Relapsing-Remitting Multiple Sclerosis
    Alroughani, Raed
    Huppke, Peter
    Mazurkiewicz-Beldzinska, Maria
    Blaschek, Astrid
    Valis, Martin
    Aaen, Gregory
    Pultz, Joe
    Peng, Xiaomei
    Beynon, Vanessa
    FRONTIERS IN NEUROLOGY, 2021, 11
  • [4] COST-EFFECTIVENESS ANALYSIS OF DELAYED-RELEASE DIMETHYL FUMARATE FOR THE TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS IN SPAIN
    Gasche, D.
    Restovic, G.
    Casado, V
    Ramirez-Boix, P.
    Martinez Lopez, J.
    VALUE IN HEALTH, 2015, 18 (07) : A755 - A755
  • [5] The cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis in Canada
    Su, Wenqing
    Kansal, Anuraag
    Vicente, Colin
    Deniz, Baris
    Sarda, Sujata
    JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (07) : 718 - 727
  • [6] Effect of aspirin on flushing in relapsing-remitting multiple sclerosis patients receiving delayed-release dimethyl fumarate
    Rog, D.
    Cader, S.
    Harrower, T.
    McGuigan, C.
    Young, C.
    Potts, J.
    Hanna, J.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 656 - 657
  • [7] Budget impact analysis of delayed-release dimethyl-fumarate in the treatment of relapsing-remitting multiple sclerosis in Italy
    Furneri, Gianluca
    Marchesi, Chiara
    Santoni, Laura
    FARMECONOMIA-HEALTH ECONOMICS AND THERAPEUTIC PATHWAYS, 2016, 17 (01) : 29 - 39
  • [8] Efficacy and safety of delayed-release dimethyl fumarate in patients newly diagnosed with relapsing-remitting multiple sclerosis (RRMS)
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Fox, Robert J.
    Zhang, Annie
    Meltzer, Leslie
    Kurukulasuriya, Nuwan C.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (01) : 57 - 66
  • [9] Overall safety and efficacy through 10 years of treatment with delayed-release dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    Gold, R.
    Giovannoni, G.
    Phillips, J. T.
    Bar-Or, A.
    Fox, R. J.
    Chen, C.
    Miller, C.
    Branco, F.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 772 - 773
  • [10] Overall Safety and Efficacy Through 10 Years of Treatment with Delayed-Release Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    Gold, Ralf
    Giovannoni, Gavin
    Phillips, J. Theodore
    Bar-Or, Amit
    Fox, Robert J.
    Chen, Chongshu
    Parks, Becky
    Kapadia, Shivani
    NEUROLOGY, 2020, 94 (15)
12345